Growth hormone deficiency in children

Pituitary

Volumn 11, Issue 2, 2008, Pages 115-120

  Richmond, Erick J ^a,b   Rogol, Alan D ^c,d  

^a National Children's Hospital   (Costa Rica)

^b UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^c UNIVERSITY OF VIRGINIA   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Growth hormone; Growth hormone deficiency; Insulin like growth factors; Provocative testing

Indexed keywords

ARGININE; CARBIDOPA PLUS LEVODOPA; CLONIDINE; GLUCAGON; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; INSULIN; LEVODOPA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CHILD GROWTH; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DROWSINESS; DRUG INDUCED HEADACHE; ENDOCRINE FUNCTION TEST; FALSE POSITIVE RESULT; FATIGUE; FLUSHING; GOLD STANDARD; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEALTH CARE COST; HORMONAL THERAPY; HORMONE RESPONSE; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INSULIN TOLERANCE TEST; LABORATORY TEST; NAUSEA; PHARMACOLOGICAL STIMULATION; PREPUBERTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECOMMENDED DRUG DOSE; REPRODUCIBILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; VERTIGO; VOMITING;

ADULT; CHILD; GONADAL STEROID HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYPOGLYCEMIC AGENTS; HYPOPITUITARISM; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PITUITARY FUNCTION TESTS; STIMULATION, CHEMICAL;

EID: 43049181771     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-008-0105-7     Document Type: Article

References (43)

1. Ranke MB, Schweizer R, Lindberg A et al (2004) Insulin-like growth factors as diagnostic tools in growth hormone deficiency during childhood and adolescence: The KIGS experience. Horm Res 62:17-25. doi: 10.1159/000080754
2. Jensen RB, Jeppesen KA, Vielwerth S et al (2005) Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 as diagnostic markers of growth hormone deficiency in infancy. Horm Res 63:15-21. doi: 10.1159/ 000082456
3. Strasburger CJ, Bidlingmaier M (2005) How robust are laboratory measures of growth hormone status? Horm Res 64:1-5. doi: 10.1159/000087745
4. Hasegawa Y, Hasegawa T, Aso T et al (1992) Usefulness and limitation of measurement of insulin-like growth factor binding protein-3 (IGFBP-3) for diagnosis of growth hormone deficiency. Eur J Endocrinol 39:585-591
5. Smith WJ, Underwood LE, Busby WH et al (1993) Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab 77:1294-1299. doi: 10.1210/jc.77.5.1294
6. Bidlingmaier M, Strasburger CJ (2007) Growth hormone assays: Current methodologies and their limitations. Pituitary 10:115-119. doi: 10.1007/ s11102-007-0030-1
7. Wieringa GE, Trainer PJ (2007) Commentary: Harmonizing growth hormone measurements: Learning lessons for the future. J Clin Endocrinol Metab 92:2874-2875. doi: 10.1210/jc.2007-0750
8. Fass B, Lippe BM, Kaplan SA (1979) Relative usefulness of three growth hormone stimulation screening tests. Am J Dis Child 133:931-933
9. Guyda HJ (2000) Growth hormone testing and the short child. Pediatr Res 48:579-580. doi: 10.1203/00006450-200011000-00003
10. Gandrud LM, Wilson DM (2004) Is growth hormone stimulation testing in children still appropriate? Growth Horm IGF Res 14:185-194. doi: 10.1016/ j.ghir.2003.11.003
11. Ghigo E, Bellone J, Aimaretti G et al (1996) Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 81:3323-3327. doi: 10.1210/ jc.81.9.3323
12. Growth Hormone Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society. GH research society. J Clin Endocrinol Metab 85:3990-3993. doi: 10.1210/ jc.85.11.3990
13. Alba-Roth J, Muller OA, Schopohl J et al (1988) Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J Clin Endocrinol Metab 67:1186-1189
14. Root AW, Saenz-Rodriguez C, Bongiovanni AM et al (1969) The effect of arginine infusion on plasma growth hormone and insulin in children. J Pediatr 74:187-197. doi: 10.1016/S0022-3476(69)80066-1
15. Merimee TJ, Rabinowitz D, Fineberg SE (1969) Arginine-initiated release of human growth hormone. Factors modifying the response in normal man. N Engl J Med 280:1434-1438
16. Mauras N, Walton P, Nicar M et al (2000) Growth hormone stimulation testing in both short and normal statured children: Use of an immunofunctional assay. Pediatr Res 48:614-618. doi: 10.1203/ 00006450-200011000-00010
17. Weldon VV, Gupta SK, Haymond MW et al (1973) The use of L-DOPA in the diagnosis of hyposomatotropism in children. J Clin Endocrinol Metab 36:42-46
18. Weldon VV, Gupta SK, Klingensmith et al (1975) Evaluation of growth hormone release in children using arginine and L-dopa in combination. J Pediatr 87:540-544. doi: 10.1016/S0022-3476(75)80816-X
19. Philippi H, Pohlenz J, Grimm W et al (2000) Simultaneous stimulation of growth hormone, adrenocorticotropin and cortisol with L-dopa/L-carbidopa and propranolol in children of short stature. Acta Paediatr 89:442-446. doi: 10.1080/080352500750028168
20. Collu R, Brun G, Milsant F et al (1978) Reevaluation of levodopa-propranolol as a test of growth hormone reserve in children. Pediatrics 61:242-244
21. Reiter EO, Martha PM (1990) Pharmacological testing of growth hormone secretion. Horm Res 33:121-126
22. Lanes R, Hurtado E (1982) Oral clonidine-an effective growth hormone-releasing agent in prepubertal subjects. J Pediatr 100:710-714. doi: 10.1016/S0022-3476(82)80569-6
23. Huang C, Banerjee K, Sochett E et al (2001) Hypoglycemia associated with clonidine testing for growth hormone deficiency. J Pediatr 139:323-324. doi: 10.1067/mpd.2001.116276
24. Lanes R, Recker B, Fort P (1985) Low-dose oral clonidine. A simple and reliable growth hormone screening test for children. Am J Dis Child 139:87-88
25. Fraser NC, Seth J, Brown NS (1983) Clonidine is a better test for growth hormone deficiency than insulin hypoglycaemia. Arch Dis Child 58:355-358
26. Takano K, Hizuka N, Asakawa K et al (1984) Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism. J Clin Endocrinol Metab 58:236-241
27. Butenandt O (1989) Diagnostic value of growth hormone-releasing hormone tests in short children. Acta Paediatr Scand 349:93-99
28. Martha PM, Blizzard RM, McDonald JA et al (1988) A persistent pattern of varying pituitary responsivity to exogenous growth hormone (GH)-releasing hormone in GH-deficient children: Evidence supporting periodic somatostatin secretion. J Clin Endocrinol Metab 67:449-454
29. Maghnie M, Salati B, Bianchi S et al (2001) Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone plus arginine in children and adults with congenital hypopituitarism. J Clin Endocrinol Metab 86:1574-1579. doi: 10.1210/jc.86.4.1574
30. Ghigo E, Bellone J, Aimaretti G et al (1996) Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 81:3323-3327. doi: 10.1210/ jc.81.9.3323
31. Ham JN, Ginsberg JP, Hendell CD et al (2005) Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy. Clin Endocrinol (Oxf) 62:628-632. doi: 10.1111/j.1365-2265.2005.02272.x
32. Maghnie M, Cavigioli F, Tinelli C et al (2002) GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset. J Clin Endocrinol Metab 87:2740-2744. doi: 10.1210/jc.87.6.2740
33. Leong KS, Walker AB, Martin I et al (2001) An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease. Clin Endocrinol (Oxf) 54:463-468. doi: 10.1046/j.1365-2265.2001.01169.x
34. Mitchell ML, Sawin CT (1972) Growth hormone response to glucagon in diabetic and nondiabetic persons. Isr J Med Sci 8:867
35. Collu R, Leboeuf G, Letarte J et al (1975) Stimulation of growth hormone secretion by levodopa-propranolol in children and adolescents. Pediatrics 56:262-266
36. Schonberger W, Ziegler R, Brodt B et al (1976) GH secretion after oral application of L-dopa and L-carbidopa. Eur J Pediatr 122:195-200. doi: 10.1007/BF00463737
37. Shah A, Stanhope R, Mathew D (1991) Hazards of pharmacological tests of growth hormone secretion in childhood. BMJ 304:173-174
38. Kaplan SL, Abrams CA, Bell JJ et al (1968) Growth and growth hormone. I. Changes in serum level of growth hormone following hypoglycemia in 134 children with growth retardation. Pediatr Res 2:43-63. doi: 10.1203/ 00006450-196801000-00005
39. Root AW, Rosenfield RL, Bongiovanni AM et al (1967) The plasma growth hormone response to insulin-induced hypoglycemia in children with retardation of growth. Pediatrics 39:844-852
40. Gonc EN, Yordam N, Kandemir N et al (2001) Comparison of stimulated growth hormone levels in primed versus unprimed provocative tests. Effect of various testosterone doses on growth hormone levels. Horm Res 56:32-37. doi: 10.1159/000048087
41. Couto-Silva AC, Trivin C, Adan L et al (2005) Management of boys with short stature and delayed puberty. J Pediatr Endocrinol Metab 18:807-813
42. Martinez AS, Domene HM, Ropelato MG et al (2000) Estrogen priming effect on growth hormone (GH) provocative test: A useful tool for the diagnosis of GH deficiency. J Clin Endocrinol Metab 85:4168-4172. doi: 10.1210/ jc.85.11.4168
43. Marin G, Domene HM, Barnes KM et al (1994) The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 79:537-541